Match tier
Institution-verified
Presence
Current · Arkansas
Last published
2026
Sources
Institutional record
Refreshed
2026-08-06
S
Sanjay Muttineni
Sourced from institutional research profiles (UAMS TRI or ARA).
Assistant Professor
Faculty Researcher
COM | Internal Med Hem-Onc
2 pubs
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Sanjay Muttineni is an Assistant Professor in Hematology-Oncology at the University of Arkansas for Medical Sciences. His research interests include the study of multiple myeloma and related blood cancers. He investigates various treatment modalities and their impact on patient outcomes, with a focus on improving care for individuals affected by these diseases.
Metrics
- Publications: 2
Selected Publications
-
The prognostic impact of lymphocyte counts and immune composition in bispecific antibody therapy in relapsed/refractory multiple myeloma (2026)
-
Long term follow up of multiple myeloma patients achieving MRD negativity at 10 <sup>-6</sup> . (2026)
-
Real-world analysis of CRS and ICANS following tarlatamab and its association with survival in patients with SCLC. (2026)
-
Real-world infectious complications and IVIG utilization after teclistamab in relapsed/refractory multiple myeloma. (2026)
-
Influence of genomic and clinical high-risk features on outcomes after BCMA-directed bispecific antibody therapy in relapsed/refractory multiple myeloma. (2026)
-
Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients (2026)
-
Cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients: Clinical outcomes and risk factors (2025)
-
Disseminated Bartonella henselae Infection in a Patient With Relapsed/Refractory Multiple Myeloma Following Autologous Stem Cell Transplantation (2025)
Collaboration Network
Top Collaborators
Sasya Dronavalli
University of Arkansas for Medical Sciences
3 shared publications
In database
- Disseminated Bartonella henselae Infection in a Patient With Relapsed/Refractory Multiple Myeloma Following Autologous Stem Cell Transplantation
- Cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients: Clinical outcomes and risk factors
- Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients
Sharmilan Thanendrarajan
University of Arkansas for Medical Sciences
3 shared publications
In database
- Disseminated Bartonella henselae Infection in a Patient With Relapsed/Refractory Multiple Myeloma Following Autologous Stem Cell Transplantation
- Cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients: Clinical outcomes and risk factors
- Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients
Frits van Rhee
University of Arkansas for Medical Sciences
2 shared publications
In database
- Disseminated Bartonella henselae Infection in a Patient With Relapsed/Refractory Multiple Myeloma Following Autologous Stem Cell Transplantation
- Cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients: Clinical outcomes and risk factors
Hira Imad Cheema
University of Arkansas for Medical Sciences
2 shared publications
In database
- Cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients: Clinical outcomes and risk factors
- Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients
Jawad Alrawabdeh
University of Jordan (JO)
2 shared publications
- Cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients: Clinical outcomes and risk factors
- Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients
Juan Carlos Rico Crescencio
University of Arkansas for Medical Sciences
1 shared publication
In database
- Disseminated Bartonella henselae Infection in a Patient With Relapsed/Refractory Multiple Myeloma Following Autologous Stem Cell Transplantation
Nikhil N. Verma
University of Arkansas for Medical Sciences (US)
1 shared publication
- Disseminated Bartonella henselae Infection in a Patient With Relapsed/Refractory Multiple Myeloma Following Autologous Stem Cell Transplantation
Asis Shrestha
University of Arkansas for Medical Sciences
1 shared publication
In database
- Cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients: Clinical outcomes and risk factors
Syed Naqvi
University of Arkansas for Medical Sciences
1 shared publication
In database
- Cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients: Clinical outcomes and risk factors
Marah Alzubi
University of Jordan (JO)
1 shared publication
- Cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients: Clinical outcomes and risk factors
Maurizio Zangari
University of Arkansas for Medical Sciences
1 shared publication
In database
- Cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients: Clinical outcomes and risk factors
John D. Shaughnessy
University of Arkansas for Medical Sciences
1 shared publication
In database
- Cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients: Clinical outcomes and risk factors
Fenghuang Zhan
University of Arkansas for Medical Sciences
1 shared publication
In database
- Cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients: Clinical outcomes and risk factors
Carolina Schinke
University of Arkansas for Medical Sciences
1 shared publication
In database
- Cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients: Clinical outcomes and risk factors
Samer Al Hadidi
Southwestern Medical Center
1 shared publication
In database
- Cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients: Clinical outcomes and risk factors
Similar Researchers
Based on overlapping research topics
Shoon Oo
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Hematopoietic Stem Cell Transplantation
Sruthi Vellanki
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Hematopoietic Stem Cell Transplantation
Kerri Hill
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Hematopoietic Stem Cell Transplantation
Monica Graziutti
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Hematopoietic Stem Cell Transplantation
Amisha Fnu
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Hematopoietic Stem Cell Transplantation
O. Makhoul
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Hematopoietic Stem Cell Transplantation